Package 69315-226-01

Brand: theophylline

Generic: theophylline
NDC Package

Package Facts

Identity

Package NDC 69315-226-01
Digits Only 6931522601
Product NDC 69315-226
Product ID 69315-226_a7dacdee-6f6b-4b85-b051-7779258a6971
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69315-226-01)

Marketing

Marketing Status
Marketed Since 2023-05-15
Brand theophylline
Generic theophylline
Sample Package No

Linked Drug Pages (1)

THEOPHYLLINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a7dacdee-6f6b-4b85-b051-7779258a6971", "openfda": {"upc": ["0369315227015", "0369315226018"], "unii": ["C137DTR5RG"], "rxcui": ["314241", "317769"], "spl_set_id": ["ac490ebf-24e1-47c4-a932-ad4dcafe7aad"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69315-226-01)", "package_ndc": "69315-226-01", "marketing_start_date": "20230515"}], "brand_name": "THEOPHYLLINE", "product_id": "69315-226_a7dacdee-6f6b-4b85-b051-7779258a6971", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "69315-226", "generic_name": "THEOPHYLLINE", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "THEOPHYLLINE", "active_ingredients": [{"name": "THEOPHYLLINE", "strength": "300 mg/1"}], "application_number": "ANDA214950", "marketing_category": "ANDA", "marketing_start_date": "20230515", "listing_expiration_date": "20261231"}